Conrad Lichtenstein PhD
Molecular Biology
Cambridge, England, United Kingdom
Connect with the speaker?
Conrad joined Nemesis Bioscience in 2014 after eight years as Chief Scientific Officer for Population Genetics Technologies where he developed methods to enable the rapid, low-cost, simultaneous analysis of candidate genes in multiple genomes and the identification of rare variants in mixed DNA samples from human, plant and microbial sources.
Following a Ph.D. in Molecular Biology under Nobel Laureate Dr. Sydney Brenner at the MRC Laboratory of Molecular Biology in Cambridge, he held a post-doctoral position at the University of Washington, Seattle. After this, he took a faculty position at Imperial College London, followed by an appointment as Professor of Molecular Biology at Queen Mary, University of London.
His research has included gene targeting in plants by homologous recombination, RNAi engineering for virus resistance in transgenic plants and transposition by DNA elements spreading antibiotic resistance in bacteria.
Following a Ph.D. in Molecular Biology under Nobel Laureate Dr. Sydney Brenner at the MRC Laboratory of Molecular Biology in Cambridge, he held a post-doctoral position at the University of Washington, Seattle. After this, he took a faculty position at Imperial College London, followed by an appointment as Professor of Molecular Biology at Queen Mary, University of London.
His research has included gene targeting in plants by homologous recombination, RNAi engineering for virus resistance in transgenic plants and transposition by DNA elements spreading antibiotic resistance in bacteria.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)
Quick Links
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com